CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
56.48
25-November-24 12:32:56
15 minutes delayed
Stocks
+0.42
+0.75%
Today's range
55.93 - 57.42
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Jul 2022 17:09:22 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2022 16:30:47 By Nasdaq GlobeNewswire
-
Crinetics Presents Clinical and Research Results at ENDO 2022
08 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
07 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
25 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
12 May 2022 16:41:57 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 May 2022 16:18:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
18 Apr 2022 16:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
12 Apr 2022 23:52:43 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Apr 2022 17:15:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
30 Mar 2022 16:02:00 By Nasdaq GlobeNewswire
-
30 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer
21 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Mar 2022 17:20:34 By Nasdaq GlobeNewswire
-
01 Mar 2022 08:00:18 By Nasdaq GlobeNewswire
-
28 Feb 2022 06:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
09 Feb 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2022 16:42:26 By Nasdaq GlobeNewswire
-
12 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
05 Jan 2022 07:30:00 By Nasdaq GlobeNewswire